title: Coccyx fractures treated with intranasal calcitonin.
abstract: BACKGROUND
  Treating pain associated with acute coccyx fractures can be challenging. Intranasal calcitonin has been used to treat acute pain after vertebral fracture, and may even accelerate fracture healing. However, intranasal calcitonin has never previously been published as part of the treatment of acute coccyx fractures.
  
  
  OBJECTIVE
  To examine a series of cases in which intranasal calcitonin was used to treat coccydynia related to coccyx fractures.
  
  
  METHODS
  Case series and literature review.
  
  
  METHODS
  Outpatient university-based coccyx pain center.
  
  
  RESULTS
  After use of intranasal calcitonin, pain levels decreased, adverse events were minimal, and the medication was generally well tolerated.
  
  
  CONCLUSIONS
  As this is not a randomized control trial, the patients treated with intranasal calcitonin were not compared to a control group. Additionally, the sample size of 8 patients is relatively small.
  
  
  CONCLUSIONS
  We propose that clinicians consider use of intranasal calcitonin for the treatment of pain due to acute coccyx fractures.
authors.affiliation: Rutgers New Jersey Medical School, Department of Physical Medicine and Rehabilitation, Newark, NJ.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Foye
authors.forename: Peter
authors.initials: P
authors.lastname: Shupper
authors.forename: Ian
authors.initials: I
authors.lastname: Wendel
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D002116:Calcitonin / Q000008:administration & dosage*; D003050:Coccyx / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016103:Spinal Fractures / Q000150:complications* / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents; D002116:Calcitonin